mrna-4157,pembrolizumab
moderna,merck
['melanoma', 'merck', 'moderna']
today, in collaboration with , we re sharing new data at #aacr23 on our investigational individualized neoantigen therapy in combination with immunotherapy in #melanoma: 
We aspire to be the premier research-intensive biopharmaceutical company. Intended for U.S. residents only. FLS: https://t.co/20VS9JL2y9